Australia markets open in 2 hours 10 minutes
  • ALL ORDS

    7,398.90
    +7.90 (+0.11%)
     
  • AUD/USD

    0.7111
    +0.0074 (+1.06%)
     
  • ASX 200

    7,148.90
    +3.30 (+0.05%)
     
  • OIL

    110.59
    +0.31 (+0.28%)
     
  • GOLD

    1,852.10
    +10.00 (+0.54%)
     
  • BTC-AUD

    41,340.31
    -1,158.32 (-2.73%)
     
  • CMC Crypto 200

    658.56
    -16.31 (-2.42%)
     

CORRECTING and REPLACING Cardiovascular Systems, Inc. to Webcast Fiscal 2022 Second-Quarter Earnings Conference Call Thursday, February 3

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Live Webcast at 8:00 a.m. CT (9:00 a.m. ET)

ST. PAUL, Minn., January 06, 2022--(BUSINESS WIRE)--In a press release issued under the same headline on January 6, by Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), please note that the registration link to participate in the conference call was inaccurate.

The updated release reads:

CARDIOVASCULAR SYSTEMS, INC. TO WEBCAST FISCAL 2022 SECOND-QUARTER EARNINGS CONFERENCE CALL THURSDAY, FEBRUARY 3

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2022 second-quarter conference call on Thursday, February 3, 2022, at 8:00 a.m. CT (9:00 a.m. ET). CSI management will discuss results for its fiscal second quarter ended December 31, 2021, and its financial outlook. CSI will issue an earnings release prior to the call on February 3, 2022.

To access the live webcast, please register for the webcast here. A webcast replay will be available later the same day.

To participate in the conference call, please register for the conference call here.

About Cardiovascular Systems, Inc.

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company’s orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives. For additional information, please visit www.csi360.com and connect on Twitter @csi360.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220106005116/en/

Contacts

Cardiovascular Systems, Inc.
Jack Nielsen
Vice President, Investor Relations & Corporate Communications
(651) 202-4919
j.nielsen@csi360.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting